Blue rubber bleb nevus syndrome screening: Difference between revisions
Farima Kahe (talk | contribs) Created page with "==Overview== There is insufficient evidence to recommend routine screening for [disease/malignancy]. OR According to the [guideline name], screening for [disease name] is..." |
Farima Kahe (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Blue rubber bleb nevus syndrome}} | |||
{{CMG}} ; {{AE}} {{VKG}} | |||
==Overview== | ==Overview== | ||
Revision as of 21:31, 23 January 2019
|
Blue rubber bleb nevus syndrome Microchapters |
|
Differentiating Blue Rubber Bleb Nevus Syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Blue rubber bleb nevus syndrome screening On the Web |
|
American Roentgen Ray Society Images of Blue rubber bleb nevus syndrome screening |
|
Directions to Hospitals Treating Blue rubber bleb nevus syndrome |
|
Risk calculators and risk factors for Blue rubber bleb nevus syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
- [Condition 1]
- [Condition 2]
- [Condition 3]